EASL

Better Test for Predicting Mortality in Liver Failure?

April 20, 2016

Article

Is a methacetin breath test superior to MELD scores in predicting mortality in liver failure?

In Liver Disease, Thick Waist is Worse than Obesity

April 20, 2016

Article

Being overweight in itself is a risk factor for non-alcoholic fatty liver disease (NAFLD), but people of normal body mass index (BMI) can have lean NAFLD and if so they are in even greater danger.

Should Liver Transplant Come Sooner in Wilson Disease?

April 19, 2016

Article

Severe neurological symptoms, not liver failure, should be the signal to start thinking about a liver transplant in Wilson Disease, French researchers say.

Australian Researcher Offers US HCV Patients Cheap Mail-Order Generic DAAs

April 19, 2016

Article

An Australian physician is sending generic DAAs made in China and India to patients with hepatitis in the US. It's part of an NIH-approved clinical trial.

Post-Transplant HCV Recurrence Treatable with DAAs

April 18, 2016

Article

Liver transplant does not always mean the end of a hepatitis infection. A California team has had success treating recurrent HCV with DAAs.

Hepatitis Concerns Add to EU Refugee Woes

April 18, 2016

Article

Public health concerns in Europe mount as data show Syrian refugees have higher rates of HBV than residents in host countries.

Panvirals Continue to Deliver Good News

April 18, 2016

Article

Delivering on predictions made at major liver disease meetings over the past year, researchers said two experimental panvirals are curing hepatitis patients who had not been helped by earlier direct-acting antivirals.

So Far, DAAs Look Safe for Kids with HCV

April 16, 2016

Article

In what researchers said was the first study of DAAs in children with HCV, UK researchers reported the drugs were effective and well tolerated. Questions remain about whther they might have any negative effects farther out.

Six Weeks on DAAs Enough for Acute Hep C?

April 16, 2016

Article

A team from Germany found patients with acute HCV infection could be cured in six weeks with DAA treatment, half the recommended time.

Hopeful News on Rare, Incurable Liver Disease: Primary Sclerosing Cholangitis

April 16, 2016

Article

The best treatment so far for primary sclerosing cholangitis, a rare and devastating inflammatory disease that typically strikes people in late adolescence or early adulthood, is liver transplant. But a phase 2 trial of norursodeoxycholic acid showed efficacy.

x